My first 70.3 was an amazing experience, one that can't be conveyed into words. I signed up for my second 70.3, which will be in Austin, on October 29, 2017. I decided to run this race for a young man named Michael. Michael is 16, and has sarcoma. His family and I will be raising money for St. Baldricks cancer research. Michael and his family choice this charity, and we will be making all donations in his name. St. Baldricks has given so much to him and his family, we wanted to give back to them. Below is Michael's story from his mother: "Michael Heras was diagnosed with Osteosarcoma, bone cancer, on May 11, 2016 at the age of 16. In December 2015 he started experiencing pain which was thought to be a muscle strain from playing basketball. After a clear X-ray and seeing three different doctors it was believed to be only a muscle strain. Due to continued pain and discomfort, an MRI was finally done on May 3, 2016 which showed a large tumor on his hip bone. A biopsy on May 11, 2016 confirmed a diagnosis of Osteosarcoma. May 23, 2016 he started chemo (MAP Protocol) with week long hospital stays for each round. While in the hospital, Michael fell and broke his leg which required doctors to move up his scheduled surgery by 5 weeks. On June 29, 2016 Michael spent over 12 hours in the operating room for Limb Salvage Surgery. The tumor was removed, a hip replacement was performed and part of his femur replaced with a metal rod. In September during the middle of his 8 month long course of treatment his doctors noticed that the cancer had spread to his lungs. At that time his chemotherapy treatment was changed. This new chemo brought on severe toxicity effects and had to be stopped. In November Michael went into the ER with severe chest pains. It took a few days to realize the pain was from his enlarged appendix, which is something that happens from extremely low white blood cells, so it had to be surgically removed. After consulting with several doctors it was suggested that Michael go back to the original chemo (MAP Protocol). On May 15, 2017 Michael received his last inpatient chemo and was discharged and rang the end of treatment bell. After completing the end of treatment scan, a new tumor was found on Michael's pelvic bone and on the muscle near it. On Monday, June 26, 2017, Michael started a new course of chemotherapy treatment. He will complete 9 weeks of treatment in hopes that the tumor shrinks for surgery in late August 2017. This new chemo is the last and least effective chemo that is available for Osteosarcoma. What also lies ahead is a possible Hemipelvectomy in hwhich Michael may lose his right leg and a portion of his pelvis to remove the new tumor as well as a lung surgery to remove the cancerous nodules. A cancer diagnosis of any kind can be devastating to a family in many ways: physically, emotionally, and financially. To date, the tax payer funded National Cancer Institute (NCI) dedicates approximately only 4% of it's annual budget to childhood cancer. In the last 20 years, only 3 new drugs have been approved that were specifically developed to treat children with cancer. Childhood cancer is not one disease - there are over a dozen types and countless subtypes, each requiring specific research to develop the best treatment. Two-thirds of children treated for cancer will suffer long-term effects from treatment including loss of hearing and sight, heart disease, secondary cancers, learning disabilities, infertility and more. Our children deserve better!"